Ca SkiHomo sapiens (Human)Cancer cell line

Also known as: CASKI, Caski, CaSki, Ca-Ski

🤖 AI SummaryBased on 14 publications

Quick Overview

Cervical cancer cell line with HPV16 infection, used in cancer research.

Detailed Summary

Ca Ski is a cervical cancer cell line derived from a squamous cell carcinoma of the cervix. It is known for its HPV16 infection, which plays a significant role in its oncogenic properties. The cell line is widely used in research to study the molecular mechanisms of cervical cancer, including the effects of HPV on cellular processes and the development of targeted therapies. Ca Ski cells are also utilized to investigate the role of specific genes and pathways in cancer progression and response to treatment.

Research Applications

HPV infection studiesCancer biology researchDrug developmentGenomic and transcriptomic analysis

Key Characteristics

HPV16 positiveUsed in cervical cancer researchGenomic instabilityExpression of viral oncogenes E6 and E7
Generated on 6/16/2025

Basic Information

Database IDCVCL_1100
SpeciesHomo sapiens (Human)
Tissue SourceSmall intestine[UBERON:UBERON_0002108]

Donor Information

Age40
Age CategoryAdult
SexFemale

Disease Information

DiseaseSquamous cell carcinoma of the cervix uteri
LineageCervix
SubtypeCervical Squamous Cell Carcinoma
OncoTree CodeCESC

DepMap Information

Source TypeATCC
Source IDACH-001336_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationNone reportedTP53---PubMed=19787792
MutationSimplePIK3CAp.Glu545Lys (c.1633G>A)Heterozygous-from parent cell line MCF-7
MutationSimpleKMT2Dp.Gln4079Ter (c.12235C>T)Heterozygous-Unknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
8,12
D16S539
11,12
D18S51
17
D19S433
15,16
D21S11
30
D2S1338
21
D3S1358
15
D5S818
13
D7S820
8,11
D8S1179
15
FGA
21
Penta D
10
Penta E
5
TH01
7
TPOX
8
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines.

Frederick M.J., Myers J.N., Pickering C.R., Johnson F.M.

Oncotarget 8:86369-86383(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.

Symer D.E., Gillison M.L.

Genome Res. 24:185-199(2014).

Individual karyotypes at the origins of cervical carcinomas.";

Duesberg P.H.

Mol. Cytogenet. 6:44.1-44.23(2013).

Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines.

Rangel-Lopez A., Kofman S., Berumen J.

PLoS ONE 7:E32667-E32667(2012).

The HPV transcriptome in HPV16 positive cell lines.";

Schmitt M., Pawlita M.

Mol. Cell. Probes 25:108-113(2011).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Biological properties of Caski cell lines induced by exposing to the space environment.

Yang C., Li G.-C., Li Y.-H., Hu J.-Y., Xiao Y., Zhang Z.-J.

Zhong Nan Da Xue Xue Bao Yi Xue Ban 32:380-386(2007).

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Gorter A., Kenter G.G., Fleuren G.J., Jordanova E.S.

BMC Genomics 8:53.1-53.13(2007).

Smad4 deficiency in cervical carcinoma cells.";

Schwarte-Waldhoff I.

Oncogene 24:810-819(2005).

Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines.

Meissner J.D.

J. Gen. Virol. 80:1725-1733(1999).

p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.

Syrjanen S.M.

Gynecol. Oncol. 71:352-358(1998).

The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay.

Rantanen V., Grenman S.E., Kulmala J., Grenman R.

J. Cancer Res. Clin. Oncol. 121:230-234(1995).

In vitro response of cervical cancer cell lines CaSki, HeLa, and ME-180 to the antiestrogen tamoxifen.

Grenman S.E., Shapira A., Carey T.E.

Gynecol. Oncol. 30:228-238(1988).

Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines.

Howley P.M.

J. Virol. 61:962-971(1987).

Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

Yee C., Krishnan-Hewlett I., Baker C.C., Schlegel R., Howley P.M.

Am. J. Pathol. 119:361-366(1985).

Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line.

Mattingly R.F.

Science 196:1456-1458(1977).

Web Resources